BridgeMD
New treatment option for Hyponatremia
Official title Regulation of Extracellular Sodium in End Stage Renal Disease Upon Volume and Electrolyte Challenges
ClinicalTrials.gov ID: NCT06408077
What this study is testing
- What it's testing
- Hyponatremia is the most common electrolyte disorder of all and can be observed in more than 30% of all patients in hospitals. Osmotic homeostasis of body fluids is essential for survival of all living creatures.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult patients ≥18 years
- Requirement of renal replacement therapy due to surgical (i.e., nephrectomy) or non-surgical (chronic kidney disease) reason
- Stable hemodialysis treatment for at least 3 months
- Urine output \<100ml in 24 hours
- Glucose-corrected plasma sodium between 135 mmol/l and 145 mmol/l
You likely can't join if
- Peritoneal dialysis patients
- Signs of volume expansion or contraction
- Congestive heart failure (NYHA ≥2)
- acute illness (infection, congestive heart failure, liver cirrhosis, etc.) requiring hospital admission
- Uncontrolled arterial hypertension
- Hemoglobin ≤8g/dL
See the full eligibility criteria
- Adult patients ≥18 years
- Requirement of renal replacement therapy due to surgical (i.e., nephrectomy) or non-surgical (chronic kidney disease) reason
- Stable hemodialysis treatment for at least 3 months
- Urine output \<100ml in 24 hours
- Glucose-corrected plasma sodium between 135 mmol/l and 145 mmol/l
- Plasma potassium between 3.5 mmol/l and 5 mmol/l
- Written informed consent
- Peritoneal dialysis patients
- Signs of volume expansion or contraction
- Congestive heart failure (NYHA ≥2)
- acute illness (infection, congestive heart failure, liver cirrhosis, etc.) requiring hospital admission
- Uncontrolled arterial hypertension
- Hemoglobin ≤8g/dL
- Alcohol abuse
- Malnutrition
- Persons, who are in a dependency/employment relationship with the investigators
- Accommodation in an institution by judicial or administrative order
The study team makes the final eligibility decision.
Where it's taking place
- Cologne, Germany
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cologne, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.